Status:
COMPLETED
Epidermal Cell Transplantation in Vitiligo Skin With and Without Narrow-band Ultraviolet B (UVB) Treatment
Lead Sponsor:
Medical University of Graz
Conditions:
Vitiligo
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
The effect of treatment with narrow-band UVB 311 nm after transplantation of harvested autologous epidermal cells on vitiligo lesions will be investigated.
Detailed Description
Introduction: Surgical interventions in vitiligo are widely used and additional UV exposure is often recommended after successful transplantation. However, little is known about the additional efficac...
Eligibility Criteria
Inclusion
- 11 female or male vitiligo patients between the age of 18 and 70
- Stable vitiligo for at least 1 year
Exclusion
- Progressive disease within the last 12 months
- Sporadic repigmentation of single patches within the last 12 months
- Patients with contraindications for UV-treatment
- Patients with anticoagulant treatment, bleeding disorders
- Patients with prolonged wound healing in the history
- History of hypertrophic scarring or keloids or Köbner phenomenon
- Reduced general health status
- Patients with allergic reactions to local anaesthesia
- Topical steroids or calcineurin inhibitors in the last 4 weeks before study entry
- UV exposure in the last 4 weeks before study entry
- Pregnancy or lactation
Key Trial Info
Start Date :
February 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2015
Estimated Enrollment :
11 Patients enrolled
Trial Details
Trial ID
NCT00615355
Start Date
February 1 2008
End Date
December 1 2015
Last Update
January 12 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University, Department of Dermatology
Graz, Austria, 8036